EP2791161 - INHIBITORS OF HCV NS5A [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 16.12.2016 Database last updated on 24.08.2024 | Most recent event Tooltip | 12.10.2018 | Lapse of the patent in a contracting state New state(s): AL | published on 14.11.2018 [2018/46] | Applicant(s) | For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | [N/P] |
Former [2014/43] | For all designated states F.Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | Inventor(s) | 01 /
BRINKMAN, John, A. 3 Glenwood Way West Caldwell, NJ 07006 / US | 02 /
SARABU, Ramakanth 3 Candlewick Drive Towaco, NJ 07082 / US | 03 /
SO, Sung-Sau 11 Westover Road Verona, NJ 07044 / US | [2014/43] | Representative(s) | Halbig, Dirk F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124 4070 Basel / CH | [2014/43] | Application number, filing date | 12799571.0 | 13.12.2012 | [2016/06] | WO2012EP75322 | Priority number, date | US201161576641P | 16.12.2011 Original published format: US 201161576641 P | [2014/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013087743 | Date: | 20.06.2013 | Language: | EN | [2013/25] | Type: | A1 Application with search report | No.: | EP2791161 | Date: | 22.10.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.06.2013 takes the place of the publication of the European patent application. | [2014/43] | Type: | B1 Patent specification | No.: | EP2791161 | Date: | 10.02.2016 | Language: | EN | [2016/06] | Search report(s) | International search report - published on: | EP | 20.06.2013 | Classification | IPC: | C07K5/08, A61K38/06, C07D233/64, C07D237/26, A61P31/14, C07D487/04, C07D403/04, C07K5/083, C07K5/087 | [2015/27] | CPC: |
C07D403/14 (EP,US);
A61K31/4178 (EP,US);
A61K31/55 (EP,US);
A61K31/551 (EP,US);
A61K38/21 (EP,US);
A61K45/06 (US);
A61P31/12 (EP);
A61P31/14 (EP);
C07D403/04 (EP,US);
C07D487/04 (EP,US);
C07D487/06 (EP,US);
C07K5/0804 (EP,US);
C07K5/0808 (EP,US);
C07K5/0812 (EP,US);
C07K5/0821 (EP,US);
A61K38/00 (EP,US)
(-)
| C-Set: |
A61K38/21, A61K2300/00 (EP,US)
|
Former IPC [2014/43] | C07K5/08, A61K38/06, C07D233/64, C07D237/26, A61P31/14 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/43] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | HCV-NS5A-HEMMER | [2015/27] | English: | INHIBITORS OF HCV NS5A | [2014/43] | French: | INHIBITEURS DE NS5A DE VHC | [2014/43] |
Former [2014/43] | HCV-NS5A-SHEMMER | Entry into regional phase | 16.07.2014 | National basic fee paid | 16.07.2014 | Designation fee(s) paid | 16.07.2014 | Examination fee paid | Examination procedure | 16.07.2014 | Examination requested [2014/43] | 03.09.2014 | Amendment by applicant (claims and/or description) | 01.07.2015 | Communication of intention to grant the patent | 12.10.2015 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 26.10.2015 | Communication of intention to grant the patent | 17.11.2015 | Fee for grant paid | 17.11.2015 | Fee for publishing/printing paid | 17.11.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 01.07.2015 | Opposition(s) | 11.11.2016 | No opposition filed within time limit [2017/03] | Fees paid | Renewal fee | 05.12.2014 | Renewal fee patent year 03 | 07.12.2015 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 13.12.2012 | AL | 10.02.2016 | AT | 10.02.2016 | BE | 10.02.2016 | CY | 10.02.2016 | CZ | 10.02.2016 | DK | 10.02.2016 | EE | 10.02.2016 | FI | 10.02.2016 | HR | 10.02.2016 | LT | 10.02.2016 | LV | 10.02.2016 | MC | 10.02.2016 | MK | 10.02.2016 | NL | 10.02.2016 | PL | 10.02.2016 | RO | 10.02.2016 | RS | 10.02.2016 | SE | 10.02.2016 | SI | 10.02.2016 | SK | 10.02.2016 | SM | 10.02.2016 | BG | 10.05.2016 | NO | 10.05.2016 | GR | 11.05.2016 | IS | 10.06.2016 | PT | 13.06.2016 | [2018/46] |
Former [2018/30] | HU | 13.12.2012 | |
AT | 10.02.2016 | ||
BE | 10.02.2016 | ||
CY | 10.02.2016 | ||
CZ | 10.02.2016 | ||
DK | 10.02.2016 | ||
EE | 10.02.2016 | ||
FI | 10.02.2016 | ||
HR | 10.02.2016 | ||
LT | 10.02.2016 | ||
LV | 10.02.2016 | ||
MC | 10.02.2016 | ||
MK | 10.02.2016 | ||
NL | 10.02.2016 | ||
PL | 10.02.2016 | ||
RO | 10.02.2016 | ||
RS | 10.02.2016 | ||
SE | 10.02.2016 | ||
SI | 10.02.2016 | ||
SK | 10.02.2016 | ||
SM | 10.02.2016 | ||
BG | 10.05.2016 | ||
NO | 10.05.2016 | ||
GR | 11.05.2016 | ||
IS | 10.06.2016 | ||
PT | 13.06.2016 | ||
Former [2017/47] | AT | 10.02.2016 | |
BE | 10.02.2016 | ||
CZ | 10.02.2016 | ||
DK | 10.02.2016 | ||
EE | 10.02.2016 | ||
FI | 10.02.2016 | ||
HR | 10.02.2016 | ||
LT | 10.02.2016 | ||
LV | 10.02.2016 | ||
MC | 10.02.2016 | ||
NL | 10.02.2016 | ||
PL | 10.02.2016 | ||
RO | 10.02.2016 | ||
RS | 10.02.2016 | ||
SE | 10.02.2016 | ||
SI | 10.02.2016 | ||
SK | 10.02.2016 | ||
SM | 10.02.2016 | ||
BG | 10.05.2016 | ||
NO | 10.05.2016 | ||
GR | 11.05.2016 | ||
IS | 10.06.2016 | ||
PT | 13.06.2016 | ||
Former [2017/16] | AT | 10.02.2016 | |
BE | 10.02.2016 | ||
CZ | 10.02.2016 | ||
DK | 10.02.2016 | ||
EE | 10.02.2016 | ||
FI | 10.02.2016 | ||
HR | 10.02.2016 | ||
LT | 10.02.2016 | ||
LV | 10.02.2016 | ||
NL | 10.02.2016 | ||
PL | 10.02.2016 | ||
RO | 10.02.2016 | ||
RS | 10.02.2016 | ||
SE | 10.02.2016 | ||
SI | 10.02.2016 | ||
SK | 10.02.2016 | ||
SM | 10.02.2016 | ||
BG | 10.05.2016 | ||
NO | 10.05.2016 | ||
GR | 11.05.2016 | ||
IS | 10.06.2016 | ||
PT | 13.06.2016 | ||
Former [2017/03] | AT | 10.02.2016 | |
BE | 10.02.2016 | ||
CZ | 10.02.2016 | ||
DK | 10.02.2016 | ||
EE | 10.02.2016 | ||
FI | 10.02.2016 | ||
HR | 10.02.2016 | ||
LT | 10.02.2016 | ||
LV | 10.02.2016 | ||
NL | 10.02.2016 | ||
PL | 10.02.2016 | ||
RO | 10.02.2016 | ||
RS | 10.02.2016 | ||
SE | 10.02.2016 | ||
SK | 10.02.2016 | ||
SM | 10.02.2016 | ||
NO | 10.05.2016 | ||
GR | 11.05.2016 | ||
IS | 10.06.2016 | ||
PT | 13.06.2016 | ||
Former [2016/50] | AT | 10.02.2016 | |
CZ | 10.02.2016 | ||
DK | 10.02.2016 | ||
EE | 10.02.2016 | ||
FI | 10.02.2016 | ||
HR | 10.02.2016 | ||
LT | 10.02.2016 | ||
LV | 10.02.2016 | ||
NL | 10.02.2016 | ||
PL | 10.02.2016 | ||
RO | 10.02.2016 | ||
RS | 10.02.2016 | ||
SE | 10.02.2016 | ||
SK | 10.02.2016 | ||
SM | 10.02.2016 | ||
NO | 10.05.2016 | ||
GR | 11.05.2016 | ||
IS | 10.06.2016 | ||
PT | 13.06.2016 | ||
Former [2016/49] | AT | 10.02.2016 | |
DK | 10.02.2016 | ||
EE | 10.02.2016 | ||
FI | 10.02.2016 | ||
HR | 10.02.2016 | ||
LT | 10.02.2016 | ||
LV | 10.02.2016 | ||
NL | 10.02.2016 | ||
PL | 10.02.2016 | ||
RS | 10.02.2016 | ||
SE | 10.02.2016 | ||
NO | 10.05.2016 | ||
GR | 11.05.2016 | ||
IS | 10.06.2016 | ||
PT | 13.06.2016 | ||
Former [2016/46] | AT | 10.02.2016 | |
DK | 10.02.2016 | ||
FI | 10.02.2016 | ||
HR | 10.02.2016 | ||
LT | 10.02.2016 | ||
LV | 10.02.2016 | ||
NL | 10.02.2016 | ||
PL | 10.02.2016 | ||
RS | 10.02.2016 | ||
SE | 10.02.2016 | ||
NO | 10.05.2016 | ||
GR | 11.05.2016 | ||
IS | 10.06.2016 | ||
PT | 13.06.2016 | ||
Former [2016/39] | AT | 10.02.2016 | |
FI | 10.02.2016 | ||
HR | 10.02.2016 | ||
LT | 10.02.2016 | ||
LV | 10.02.2016 | ||
NL | 10.02.2016 | ||
PL | 10.02.2016 | ||
RS | 10.02.2016 | ||
SE | 10.02.2016 | ||
NO | 10.05.2016 | ||
GR | 11.05.2016 | ||
IS | 10.06.2016 | ||
PT | 13.06.2016 | ||
Former [2016/38] | AT | 10.02.2016 | |
FI | 10.02.2016 | ||
HR | 10.02.2016 | ||
LT | 10.02.2016 | ||
NL | 10.02.2016 | ||
PL | 10.02.2016 | ||
NO | 10.05.2016 | ||
GR | 11.05.2016 | ||
IS | 10.06.2016 | ||
PT | 13.06.2016 | ||
Former [2016/36] | AT | 10.02.2016 | |
FI | 10.02.2016 | ||
HR | 10.02.2016 | ||
LT | 10.02.2016 | ||
NL | 10.02.2016 | ||
PL | 10.02.2016 | ||
NO | 10.05.2016 | ||
GR | 11.05.2016 | ||
Former [2016/35] | FI | 10.02.2016 | |
HR | 10.02.2016 | ||
NO | 10.05.2016 | ||
GR | 11.05.2016 | Cited in | International search | [A] - CORDEK, "TARGETS TO WATCH-Targeting the NS5A protein of HCV: An emerging option", DRUGS OF THE FUTURE, (201109), vol. 36, no. 9, ISSN 0377-8282, page 691, XP055036059 [A] 1-17 * figures 5, 6; table III * DOI: http://dx.doi.org/10.1358/dof.2011.036.09.1641618 | by applicant | EP0365030 | WO9740028 | WO9817679 | WO9822496 | US5807876 | WO9840381 | WO9901582 | WO9907734 | WO0006529 | WO0009543 | WO0010573 | WO0013708 | WO0018231 | US6054472 | WO0056331 | WO0132153 | WO0185172 | WO0204425 | US6344465 | WO0218369 | WO02100851 | WO02100846 | US6498178 | WO03000254 | WO03007945 | WO03010141 | WO03037893 | WO03037894 | WO03037895 | WO2005073216 | WO2005073195 | WO2007070433 | WO2008021927 | - JOURNAL OF MEDICINAL CHEMISTRY, (1986), vol. 29, no. 6, pages 1065 - 80 | - JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1: ORGANIC AND BIO-ORGANIC CHEMISTRY (1972-1999, (1983), pages 809 - 11 | - JOURNAL OF HETEROCYCLIC CHEMISTRY, (1994), vol. 31, no. 5, pages 1121 - 3 | - ATTWOOD, M. R ET AL., JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1: ORGANIC AND BIO-ORGANIC CHEMISTRY (1972-1999, (1986), pages 1011 - 19 | - FIESER; FIESER'S, Reagents for Organic Synthesis, WILEY & SONS, (1991), vol. 1-15 | - RODD'S, Chemistry of Carbon Compounds, ELSEVIER SCIENCE PUBLISHERS, (1989), vol. 1-5 | - Organic Reactions, WILEY & SONS, (1991), vol. 1-40 | - R. BARTENSCHLAGER, J VIROL., (200303), vol. 77, no. 5, pages 3007 - 19 | - J VIROL., (2001), vol. 77, pages 5352 - 59 |